Company intelligence / Profile preview

Birnie Capital

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Birnie Capital is a London-based venture capital firm exclusively focused on the life sciences sector. The firm specializes in identifying, investing in, and building companies that develop transformative medicines and innovative therapeutic platforms. Birnie Capital typically engages with early-stage biotech startups, providing both financial backing and strategic guidance to advance novel science toward clinical application. Their investment strategy emphasizes high-impact modalities and therapeutic areas with significant unmet medical needs.

Industry: Investors

Beyond the preview

Go deeper on Birnie Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Birnie Capital.

Explore the full profile